Women are generally less represented as first author among original medical researches and clinical guidelines. Indeed, women are first authors in only 30% of clinical guidelines published in high impact medical journals.[@R1] Nevertheless, the trend seems to be improving over the last 20 years but it has plateaued in recent years.[@R3] It is not known if a comparable under-representation occurs also in rheumatological guidelines. We have conducted a bibliometric analysis to evaluate the representation of female authors in rheumatological guidelines and recommendations over a period of time between 2004 and 2019. We searched PubMed for guidelines and recommendations published in English in the rheumatological field from 1 January 2004 to 1 January 2019. We included all guidelines and recommendations, published by rheumatologists and rheumatology health-related professionals in rheumatology journals. Gender of each first author (man or woman) was determined by use of a minimum of two resources (ie, author's name and an internet search to identify the author's photograph or gender pronoun).

We found 366 guidelines and recommendations published between 2004 and 2019 ([table 1](#T1){ref-type="table"}: stratified by disease). Overall, the proportion of female first authors was 32.0% (95% CI 28.0% to 35.0%). After stratification by year of publication the percentage of female first authors was lower in past years compared with recent years. We found an association between year of publication and the proportion of female first author ([figure 1](#F1){ref-type="fig"}). Indeed, the percentage of female first author seemed to substantially increase over the last 15 years ([figure 2](#F2){ref-type="fig"}). We analysed the proportion of female first author stratified by disease topic ([table 1](#T1){ref-type="table"}). The large majority of guidelines and recommendations were published on rheumatoid arthritis (n=96) followed by psoriatic arthritis/spondyloarthritis (n=73) and osteoarthritis (n=34). With the only exception of polymyositis and dermatomyositis (50%/50%) all the authorships were dominated by males.
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###### 

Percentage of female and male first author of rheumatological guidelines stratified by disease

  Disease                                            Female (%)   Male (%)
  -------------------------------------------------- ------------ ----------
  Osteoarthritis (n=34)                              26.5         73.5
  Rheumatoid arthritis (n=96)                        18.8         81.2
  Fibromyalgia (n=30)                                20           80
  Lupus erythematosus (n=29)                         34.5         65.5
  Psoriatic arthritis and spondyloarthritis (n=73)   23.3         76.7
  Sjogren syndrome (n=5)                             40           60
  Gout (n=19)                                        10.5         89.5
  Systemic sclerosis (n=18)                          16.7         83.3
  Polymyalgia and giant cells' arteritis (n=12)      0            100
  Osteoporosis (n=26)                                30.8         69.2
  ANCA associated vasculitides (n=14)                21.4         78.6
  Polymyositis and dermatomyositis (n=6)             50           50
  Behcet's disease (n=4)                             25           75

Overall, we found a large prevalence of male as first authors of guidelines and recommendations in the rheumatological field published between January 2004 and January 2019. The EULAR Task Force on Gender Equity in Academic Rheumatology has been recently established, making an important first step toward gender equity in the authorship of guidelines in the rheumatological fields. Indeed, in the last 15 years we have witnessed an increase in female representativeness. Notwithstanding, efforts should be made to improve the representation of female authors nationally and internationally.
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